Issues in the treatment of epilepsy.
Leppik
I E
IE
MINCEP Epilepsy Care and Department of Neurology and Pharmacy, University of Minnesota, Minneapolis, 55416, USA.
D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017277:Drug Approval; D004347:Drug Interactions; D004827:Epilepsy / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008297:Male; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States
D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam